MECURE

MeCure Industries Plc is a high-quality Nigerian healthcare manufacturer posting strong fundamental momentum — H1 2026 revenue grew 20% to ₦44.8bn with EBIT up 41%, and FY2025 ROE of ~29–38% (filing-derived and independently corroborated) speaks to a genuinely capital-efficient franchise. However, at the current price of ₦56.20, the stock trades at a independently confirmed P/E of ~31x and P/B of ~10x, representing a 44% premium to our blended fair value base of ₦31.25, with no margin of safety even in the bull scenario of ₦44.09. The quality case is real but the valuation case is not — disciplined investors should await a meaningful re-rating before entering.

Verdict published 2026-10-26 · fundamentals through Q3-2026 · reviewed as the data changes